BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7929916)

  • 21. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latest insights into pathogenesis of mycosis fungoides and cutaneous T-cell lymphoma.
    McGirt LY
    G Ital Dermatol Venereol; 2017 Apr; 152(2):158-168. PubMed ID: 27982549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
    Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage.
    Hallermann C; Kaune KM; Tiemann M; Kunze E; Griesinger F; Mitteldorf C; Bertsch HP; Neumann C
    Ann Hematol; 2007 Jul; 86(7):509-15. PubMed ID: 17340135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous T-cell lymphoma: CT in evaluation and staging.
    Bass JC; Korobkin MT; Cooper KD; Kane NM; Platt JF
    Radiology; 1993 Jan; 186(1):273-8. PubMed ID: 8416579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients.
    Rijlaarsdam JU; Scheffer E; Meijer CJ; Willemze R
    Cancer; 1992 Feb; 69(3):717-24. PubMed ID: 1730122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
    Marks E; Shi Y; Wang Y
    Virchows Arch; 2019 Nov; 475(5):637-648. PubMed ID: 31218405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-cell transformation of mycosis fungoides occurring at the site of previously treated cutaneous B-cell lymphoma.
    Herrmann JL; Sami N
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e43-6. PubMed ID: 24220618
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiological trends in cutaneous lymphomas in Greece.
    Kaliampou S; Nikolaou V; Niforou A; Kotsiopoulou I; Gerochristou M; Papanikolaou A; Kanellis G; Papadavid E; Tsimpidakis A; Pouliou E; Economaki E; Panou E; Nikolaou C; Stratigos AJ; Naska A; Marinos L
    Eur J Dermatol; 2023 Dec; 33(6):664-673. PubMed ID: 38465548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: composite lymphoma.
    Steinhoff M; Hummel M; Assaf C; Anagnostopoulos I; Treudler R; Geilen CC; Stein H; Orfanos CE
    J Clin Pathol; 2004 Mar; 57(3):329-31. PubMed ID: 14990612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study.
    Eder J; Rogojanu R; Jerney W; Erhart F; Dohnal A; Kitzwögerer M; Steiner G; Moser J; Trautinger F
    PLoS One; 2016; 11(11):e0163661. PubMed ID: 27893746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
    Su IJ; Tsai TF; Cheng AL; Chen CC
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular cutaneous T-cell lymphoma: a clinicopathological study of nine cases.
    Hodak E; Feinmesser M; Segal T; Yosipovitch G; Lapidoth M; Maron L; Bergman R; Sahar D; David M
    Br J Dermatol; 1999 Aug; 141(2):315-22. PubMed ID: 10468808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression. The French Study Group on Cutaneous Lymphoma.
    Courville P; Wechsler J; Thomine E; Vergier B; Fonck Y; Souteyrand P; Beylot-Barry M; Bagot M; Joly P
    Br J Dermatol; 1999 Mar; 140(3):421-6. PubMed ID: 10233260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.